Holen Sie sich die Stockscreener-App
89.52
2.99%
2.60
Handel nachbörslich:
89.53
0.01
+0.01%
Schlusskurs vom Vortag:
$86.92
Offen:
$87.48
24-Stunden-Volumen:
14.96M
Relative Volume:
1.44
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.94%
1M Leistung:
+2.87%
6M Leistung:
-1.38%
1J Leistung:
-7.66%
1-Tages-Spanne:
$87.27
$89.80
1-Wochen-Bereich:
$84.52
$89.80
52-Wochen-Spanne:
$66.66
$105.47
Spdr Biotech Etf Stock (XBI) Company Profile
Firmenname
Spdr Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XBI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
89.52 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
317.66 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
644.89 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
648.11 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
249.95 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.34 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Aktie (XBI) Neueste Nachrichten
US Bancorp DE Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Zurcher Kantonalbank Zurich Cantonalbank Sells 19,021 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Is It Time to Buy Biotech Stocks? - The Motley Fool
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp - Defense World
BBH- A Biotech Fund That's Ripe for a Major Turnaround - Yahoo Finance
SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Large Growth in Short Interest - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC - Defense World
N.E.W. Advisory Services LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Lyell Wealth Management LP Has $1.18 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
BREAKING: Surprise FDA Exit May Boost Biotech ETF XBI - AInvest
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
Letko Brosseau & Associates Inc. Has $3.24 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Cetera Investment Advisers Buys 5,604 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
IFP Advisors Inc Decreases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News
(XBI) Trading Advice - news.stocktradersdaily.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC - Defense World
Cerity Partners LLC Has $1.51 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD. - Defense World
SPDR S&P Biotech ETF Options Spot-On: On July 15th, 99,099 Contracts Were Traded, With 717.92K Open Interest - 富途牛牛
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now. - Barron's
XBI ETF: Riding the Pharma-Biotech Consolidation Wave - AInvest
Biotech Stocks Are Ready to Rebound. 3 to Watch Now. - Barron's
(XBI) Investment Analysis and Advice - news.stocktradersdaily.com
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Biotech ETFs: Navigating Growth and Stability in a Volatile Landscape - AInvest
Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI - Seeking Alpha
XBI, ALNY, EXEL, UTHR: Large Inflows Detected at ETF - Nasdaq
How to Take Advantage of moves in (XBI) - news.stocktradersdaily.com
Notable ETF Outflow DetectedXBI, INSM, ALNY, BPMC - Nasdaq
Learn to Evaluate (XBI) using the Charts - news.stocktradersdaily.com
Dynamic Advisor Solutions LLC Takes $825,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
3,309 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Bought by Park Avenue Securities LLC - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by GAMMA Investing LLC - Defense World
Long Term Trading Analysis for (XBI) - news.stocktradersdaily.com
Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise
How Is Vertex Pharmaceuticals’ Stock Performance Compared to Other Biotech Stocks? - The Globe and Mail
Northern Trust Corp Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Nasdaq
Hedge Funds Question Market Rally, Build Massive Short WallAmer Sports (NYSE:AS), First Solar (NASDAQ:FSLR) - Benzinga
SPDR S&P Biotech ETF Options Spot-On: On May 20th, 60,435 Contracts Were Traded, With 631.38K Open Interest - 富途牛牛
Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment - Benzinga
Finanzdaten der Spdr Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für Spdr Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):